ICCC insider transaction filings
IMMUCELL CORP /DE/ — 23 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-22. Screen ICCC transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | te Boekhorst Paul Francis Olivier — President and CEO, Director | Purchase (P): 8,000 @ $9.49 | EDGAR |
| 2026-04-16 | 4 | Basse Gloria F — Director | Grant/award (A): 11,933 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Turner Kathy V — Director | Grant/award (A): 17,899 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Wainman Paul R — Director | Grant/award (A): 11,933 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Tomsche David Scott — Director | Grant/award (A): 11,933 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Gathagan Bryan K. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Basse Gloria F — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Rosgen Steven T. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Wainman Paul R — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Brockmann Bobbi Jo — VP of Sales and Marketing, Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | Tomsche David Scott — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | BRIGHAM MICHAEL F — Director | Option exercise (M): 25,000 @ $5.84 · Tax withholding (F): 24,052 @ $6.07 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4/A | te Boekhorst Paul Francis Olivier — President and CEO, Director | Grant/award (A): 109,500 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | te Boekhorst Paul Francis Olivier — President and CEO, Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | Fiori Timothy C — Chief Financial Officer, Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | Brockmann Bobbi Jo — VP of Sales and Marketing, Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4/A | te Boekhorst Paul Francis Olivier — President and CEO, Director | Purchase (P): 3,598 @ $5.04 · Purchase (P): 2,432 @ $5.50 | EDGAR |
| 2025-12-03 | 4 | te Boekhorst Paul Francis Olivier — President and CEO, Director | Purchase (P): 3,708 @ $4.87 · Purchase (P): 2,556 @ $5.00 · Purchase (P): 3,521 @ $5.04 | EDGAR |
| 2025-11-28 | 4 | Tomsche David Scott — Director | Purchase (P): 1,633 @ $4.76 · Purchase (P): 1,633 @ $4.76 | EDGAR |
| 2025-11-12 | 4 | te Boekhorst Paul Francis Olivier — President and CEO, Director | Grant/award (A): 74,277 (derivative) @ $6.10 | EDGAR |
| 2025-06-13 | 4 | Basse Gloria F — Director | Option exercise (M): 3,530 @ $4.81 · Option exercise (M): 11,470 (derivative) @ $0 · Option exercise (M): 3.53 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Gathagan Bryan K. — Director | Purchase (P): 1,000 @ $6.32 | EDGAR |
| 2025-04-23 | 4 | Fiori Timothy C — Chief Financial Officer | Grant/award (A): 30,000 (derivative) @ $5.49 | EDGAR |
Recent 8-K events — IMMUCELL CORP /DE/
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-04-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ICCC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →